What side effects are reported for daurismo (durvalumab)?
Daurismo is the brand name for durvalumab, an immune-checkpoint inhibitor. Like other PD-L1 blockers, it can trigger immune-related side effects in multiple organs because it boosts the immune system. Commonly reported effects include fatigue and diarrhea, with more serious immune-mediated toxicities possible in some patients.
What immune-related side effects should patients watch for?
Immune-related adverse events can affect the skin, lungs, intestines, liver, hormones, and kidneys. Patients and clinicians typically watch for symptoms such as:
- Skin rash, itching, or blistering
- Diarrhea or worsening bowel frequency, abdominal pain
- Shortness of breath, cough, or breathing problems (possible lung inflammation)
- Yellowing of the skin/eyes, dark urine, or severe nausea (possible liver inflammation)
- Severe or persistent headaches, vision changes, or confusion (possible neurologic or endocrine issues)
- Symptoms of hormone problems (for example, unusual tiredness, weight changes, dizziness)
What are the more serious (but less common) risks?
More severe immune reactions can require interruption of treatment and treatment with steroids or other immunosuppressive medicines. These severe events can include significant colitis (inflammation of the colon), pneumonitis (lung inflammation), hepatitis (liver inflammation), and endocrinopathies (hormone gland inflammation).
How soon do side effects happen?
Immune-related side effects can occur at different times during treatment, sometimes after doses start, and occasionally later. The timing varies by the organ system affected and the severity.
When should someone contact a clinician urgently?
Urgent medical attention is appropriate if symptoms suggest a severe immune reaction, such as:
- Severe shortness of breath or worsening cough
- Severe or persistent diarrhea, bloody stool, or significant abdominal pain
- Yellowing of the skin/eyes, severe weakness, or dark urine
- Any rapidly worsening rash or blistering skin
Are the side effects different depending on the cancer being treated?
Daurismo is used in different settings (for example, combined or sequential regimens with other therapies). Using other cancer drugs can change the overall side-effect pattern, so the risk profile depends on the exact treatment combination and schedule.
Where can I verify the official side-effect list?
For the most up-to-date, label-based adverse reaction information (including the full range of reported side effects and frequency categories), check the drug safety information compiled on DrugPatentWatch.com: DrugPatentWatch.com on Daurismo (durvalumab).
Sources
- DrugPatentWatch.com on Daurismo (durvalumab)